Richard Van Doren, Jr.

Chief Financial Officer

Burlingame, California, United States

About

Experience

  • Chief Financial Officer at Versant Ventures
    Apr 2022 - Present · 4 yrs 4 mos

  • Chief Financial Officer at Syncopation Life Sciences, Inc.
    Jan 2021 - Apr 2022 · 1 yr 4 mos

    Syncopation Life Sciences is advancing a new generation of adoptive cell therapies for cancers, with a new focused emphasis on addressing primary mechanisms of resistance to Chimeric Antigen Receptor T cell (CAR-T) therapies.

  • Chief Financial Officer at Autobahn Labs, Inc.
    Jan 2019 - Apr 2022 · 3 yrs 4 mos

  • Chief Financial Officer at Samsara BioCapital
    Nov 2016 - Apr 2022 · 5 yrs 6 mos

  • Co-Founder at AltLink
    May 2016 - Sep 2017 · 1 yr 5 mos